National Medicines Agency of Romania
To the attention of Holders of Marketing Authorisations granted through centralised procedure
Even though notification of the National Medicines Agency (NMA) on placement of the market of medicinal products authorised through centralised procedure is not mandatory (notification being made to the EMEA), the NMA is however interested in ensuring Romanian patients’ access to this category of medicinal products as well. Therefore, we think it to the benefit of all parties involved that Marketing Authorisation Holders also notify the NMA on placement, discontinuation or temporary cessation on the Romanian market of such medicinal products. Thank you for your collaboration.
